Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns - 2Cyber Monday 2025 streaming deal: Get $42 off six months of Apple TV
- 3'Sex and the City' star Kim Cattrall marries longtime partner Russell Thomas in intimate London wedding
- 4FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- 5The top astronomical discoveries of 2025
- See the famous winged horse Pegasus fly in the autumn night sky
- Rocket shines under the northern lights | Space photo of the day for March 25, 2026
- The Ursid meteor shower will be the last of the year, peaking just before Christmas: What to know and how to watch
- German official report: Teen social media ban faces legal hurdles
- Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground
- UN chief warns he could refer Israel to ICJ over laws targetting UNRWA
- Vote In favor of Your Favored Shimmering Water
- Understanding Preschool Projects: Cultivating Abilities and Advancement
- Figure out How to Upgrade Your Gold Speculation Portfolio: Vital Bits of knowledge and Strategies
